Hear it first, here at VIVA!
Physicians and researchers from the U.S. and around the world will present the most groundbreaking research available in interventional medicine. These highly anticipated presentations, comprised of late-breaking clinical trials, follow-up data from major randomized trials, registries and first-in-man experiences with novel devices or drugs will be presented for the first time at VIVA 17. A multidisciplinary, international, panel of experts in the field including, physicians, scientists and regulators, will ask questions and shed light on the lasting impact of the research results presented.
Late-Breaking Clinical Trials
VIVA embargoes information presented as a late-breaking clinical trial from becoming public until after the beginning of the Late Breaking Clinical Trial Session in the General Session, as listed in the VIVA 17 Program or on the official VIVA 17 website. No publication, exhibitor or affiliated company may disseminate information until after the beginning of the Late Breaking Clinical Trial session in which it the information is being presented. All embargo times are listed in Pacific Daylight Time (PDT).